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List of abbreviations 
 
bp = base pairs 
Ca2+ = Calcium  
cc-qPCR = cell culture and quantitative PCR 
CO2 = carbon dioxide 
Ct = cycle threshold 
CV = coefficient of variation 
ddH2O = double distilled water 
DMSO = Dimethyl sulfoxide 
DNA = deoxyribo nucleic acid 
dNTP = Deoxyribonucleotide triphosphate  
DVG = Deutsche Veterinärmedizinische Gesellschaft (German Veterinary Society) 
EC50 = Effective concentration 50% 
fig = figure 
g = acceleration of gravity 
h = hour 
h p.i. = hour post inoculation 
HCl = Hydrochloric acid 
HCT-8 = Human colonic tumor (Human ileocecal adenocarcinoma) cells 
hsp 70 = heat shock protein 70 
kDa = kilo Dalton 
µg = microgram 
µl = microliter 
µM = micromolar 
M = molar 
mg = miligram 
Mg2+ = magnesium 
MgCl2 = magnesium chloride 
min = minute 
ml = millilitre 
mM = milimolar 
MTT = 3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide;  
            (Methyl-  Thaizoleblau, Thaizolylblau, Tetrazolium bromide) 
ng = nanogram 
nm = nanometer (wavelength) 
nM= nanomolar 
P = statistical probability value 
PBS = phosphate buffered saline 
qPCR = quantitative polymerase chain reaction 
r
2
 = statistical linear correlation 
ROS = reactive oxygen species 
RPMI 1640 = Roswell Park Memorial Institute 1640 
s = second 
SD = standard deviation 
spp = species 
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1 Introduction 
 
Cryptosporidium parvum is one of the most common and significant enteric pathogens among the 
apicomplexa, a phylum that includes also other important pathogens such as Toxoplasma, Isospora, 
Eimeria and Plasmodium species (GOODGAME 1996). The parasite normally causes self limiting 
diarrhoea in the immune host but disease may display particularly severe in neonatal and 
immunocompromised mammals (DUBEY et al. 1990, O’DONOGHUE 1995) resulting in economic 
loss in farm animals (DE GRAAF et al. 1999). Infected animals shed oocysts (CURRENT 1985) 
with faeces and these may be transmitted to a variety of hosts including man through contaminated 
water and food (CASEMORE et al. 1997, SMITH and ROSE 1998, DAWSON 2005, SMITH et al. 
2007), or by direct contact with the infected host (PREISER et al. 2003, KIANG et al. 2006). The 
tiny size and robustness of Cryptosporidium oocysts, high oocyst resistance to chemicals and 
environmental conditions, and the low infective dose are features of C. parvum that play a role in 
transmission and epidemiology of this parasite (CAREY et al. 2004). 
 
Presently no immunization or satisfactory specific therapeutic options are available for the control of 
cryptosporidiosis (DAS 1996, RAMRATNAM and FLANIGAN 1997, LAING 1999). Moreover, the 
parasite is resistant to most anticoccidal drugs (SMITH and CORCORAN 2004, RAMIREZ et al. 
2004) and many disinfectants (O’DONOGHUE 1995, BARBEE et al. 1999). Potent agents are 
urgently required for controlling cryptosporidiosis. Curcumin (diferuloylmethane, principal 
colouring agent of the herb Curcuma longa) is a natural polyphenolic compound reported to have 
antiprotozoal activities against Plasmodium falciparum (CUI et al. 2007), Leishmania spp. (KOIDE 
et al. 2002, DAS et al. 2008), Trypanosoma spp. (NOSE et al. 1998), and Giardia lamblia 
trophozoites (PEREZ-ARRIAGA et al. 2006). 
 
Reliable and reproducible in vivo or in vitro models are required for development and evaluation of 
new potent drugs and disinfectants. The mouse model has frequently been used to determine C. 
parvum oocyst viability after drug application and disinfection measures (KORICH et al. 1990, 
FINCH et al. 1993, ARROWOOD et al. 1996, NEUMANN et al. 2000, KAYSER et al. 2002, 
CASTRO-HERMIDA and ARES-MAZAS 2003, MELE et al. 2003). A chicken infection model for 
Eimeria tenella oocysts was standardized for routine screening of anticoccidial disinfectants 
(DAUGSCHIES et al. 2002) and is officially approved by the German Veterinary Society (DVG). 
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However, animal models are laborious, expensive, ethically concerned and quantitative results are 
less easily obtained than in in vitro models (CAMPBELL et al. 1982). For evaluation of drug effects 
against C. parvum and reliable estimation of infectivity of oocysts in vitro, the parasite must be 
cultured in human or animal cells. C. parvum demonstrates many developmental attributes common 
to enteric coccidia (O’DONOGHUE 1995). Coccidia development in cultured cells, ideally complete 
development in vitro, has been reported for only a few species prior to 1991. Comparison of various 
cell lines revealed that HCT-8 (Human ileocecal adenocarcinoma) cells best supported the life cycle 
of C. parvum (UPTON et al. 1994) suitably reflecting the ability of oocysts to cause infection of 
animals (MELONI and THOMPSON 1996, SHIN et al. 2001, JENKINS et al. 2003). Cell culture is 
successfully used to evaluate C. parvum infectivity and for quantitatively estimating inactivation of 
oocysts by disinfectants (SLIFKO et al. 1999, 2002). The methods developed for oocyst infectivity 
analysis in cell culture are similarly applied for assessing growth inhibition of Cryptosporidium by 
anticryptosporidial compounds. Methods for quantitative analysis of cell culture infection include 
enzyme-linked immunosorbent assay (WOODS et al. 1995), immunofluorescence microscopy 
(SLIFKO et al. 1997), colorimetric in situ hybridization (ROCHELLE et al. 2002) and reverse 
transcription (ROCHELLE et al. 1997). In comparison to other methods real time PCR is suitable for 
detection as well as accurate quantification of DNA and thus parasite numbers (HEID et al. 1996). It 
is reported as a fast analytical procedure for detection and quantification of Cryptosporidium in cell 
culture (MACDONALD et al. 2002, DI GIOVANNI and LECHEVALLIER 2005). 
 
We report here a combination of cell culture and quantitative PCR (cc-qPCR) suited to easily, 
reliably and reproducibly quantify reproduction of C. parvum for routine screening of 
pharmaceutical compounds and anticoccidial disinfectants under standardized conditions. The aims 
of the current studies were: 
 
1) To establish a protocol combining cell culture and qPCR (cc-qPCR) for reliable assessment 
of infectivity of C. parvum oocysts  
2) To analyse the potential of curcumin for control of C. parvum in this model  
3) To assess whether cc-qPCR may be proposed to replace the chicken infection model for 
routine testing of disinfectants.  
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2 Overview of the scientific works 
 
C. parvum was maintained in the laboratory through passage twice in a year by oral infection of a 
day old calf with oocysts (9 x 106). Oocysts were isolated from faeces by ether sedimentation and 
saturated sodium chloride flotation techniques. The cleaned oocysts were stored at 4°C in phosphate 
buffered saline (PBS, pH 7.4) supplemented with streptomycin (200 µg/ml) and amphotericin B (5 
µg/ml). Oocysts used for drug screening were stored for up to 9 months and for up to 3 months for 
inactivation assays. The excystation rates of the oocysts ranged from 56 to 82%. HCT-8 cells were 
maintained for cell culture assays and cells of less than 19 passages were used in these experiments.  
 
The cell culture infection assay was standardized for reliable and reproducible estimation of parasite 
multiplication by real time quantitative PCR (qPCR). DNA was extracted from samples using 
QIAamp mini kit (Qiagen, Hilden, Germany) and stored at -20° C if not used immediately. Each 
reaction mixture of 25 µl contained 1x PCR buffer (ABgene mastermix, AB gene limited, Surrey, 
England) supplemented with dNTP, MgCl2 and Taq-polymerase, 300 nM forward primer and 900 
nM reverse primer (each 25 µM, Biopolymer, Ulm, Germany), 30 nM of ROX reference dye (1 mM 
AB gene) and 200 nM of TaqMan Probe (25 µM, Biopolymer, Ulm, Germany). The reaction was 
performed in a Mx3000P® qPCR system (Stratagene, La Jolla, USA) with the condition of enzyme 
activation at 95°C for 15 min, 40 cycles of denaturation at 94-95°C for 15 s, and finally annealing 
and elongation at 60°C for 1 min. Each reaction was run in triplicate. The target sequence of 70 kDa 
heat shock protein (hps70) gene (single copy) of C. parvum was amplified by qPCR and reported as 
a cycle threshold (Ct) value of fluorescence signal for each sample. A standard curve was run in each 
experiment. By comparing the Ct values of unknown samples with the Ct values of the standard 
curve, the starting copy numbers (one copy gene corresponding to one sporozoite) of nucleic acid 
targets for each sample were estimated by using the software of the Mx3000P® qPCR system. 
 
2.1 Standardized cell culture infectivity assay (Publication 1, 2 and Manuscript 3) 
 
A standard cell culture infection and inactivation assay for C. parvum was established through 
optimization of HCT-8 cell culture infection in 24 and 6 well cell culture plates. HCT-8 cells were 
seeded into cell culture microplates and confluent monolayers were infected with a range of oocyst 
numbers. Infected monolayers without any morphological alteration over the experimental period 
  Overview of the scientific works    
  
 4 
were considered suitable for assessment of parasite reproduction. Furthermore, a series of heat 
inactivated (70°C for 1 h) oocyst suspensions were used to determine a suitable inoculation size at 
which non-invading parasites were completely removable by washing the monolayer (Manuscript 3). 
For cell culture infection, oocysts were directly excysted on confluent monolayers with 0.4% sodium 
taurocholate solution (excystation medium in RPMI-1640) for 3 h at 37°C with 5% CO2 allowing 
sporozoites to invade the HCT-8 cells. The monolayer was washed by growing medium (RPMI -
1640 with L-glutamine, 10% newborn calf serum and 1% sodium pyruvate) to remove the non 
infecting parasite materials. The infection was further maintained in growing medium for the entire 
incubation period. At the end of the particular incubation period the cells were harvested and 
subjected to DNA extraction (Publication 1, 2 and Manuscript 3). The sensitivity of the cc-qPCR 
assay was assessed by using different numbers of C. parvum oocysts to infect cell cultures. The 
sensitivity, linearity and reproducibility of the qPCR were also evaluated by using a dilution series of 
C. parvum infection control DNA or plasmid DNA (cloned fragment of hsp70 gene). The 
reproducibility and reliability of the methods were observed by repeated experiments. 
 
2.2 In vitro drug screening (Publication 1) 
 
The suitability of the cc-qPCR assay for screening of anticryptosporidial drugs was investigated by 
evaluating reference drugs like monensin (sodium salt, Sigma, Steinheim, Germany) and 
halofuginone bromide (Intervet, Unterschleissheim, Germany). Miltefosine 
(hexadecylphosphocholine, Orphanidis, Vienna, Austria), a drug used for treatment of Leishmania 
infection, was also tested against C. parvum by cc-qPCR. A range of concentrations were applied to 
non infected and infected monolayers over the entire incubation periods to determine the toxic effect 
on host cells and inhibitory effect on parasite multiplication in culture, respectively. The drug to be 
tested for anticryptosporidial activity was added at the final concentration to 1 ml fresh growing 
medium that was applied to the respective infected cell culture well. DNA was harvested from 
cultures before adding drug (3 h p.i., initial level of parasite invasion) and then after the end point of 
incubation with drugs. Percent relative inhibition of parasite multiplication was estimated as 
compared to non medicated control cultures.  
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2.3 In vitro effects of curcumin on C. parvum (Publication 2)  
 
Antiprotozoal activity of curcumin (diferuloylmethane, Sigma- Aldrich, Steinheim, Germany) has 
been evaluated by assessment of infectivity, invasiveness and multiplication of C. parvum in HCT-8 
cell cultures. Curcumin was dissolved in DMSO (dimethyl sulfoxide) and fresh preparations at final 
concentrations were used in all experiments. Potential toxicity of curcumin to HCT-8 cells was 
determined by MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide)]. The 
suitability of curcumin pre-treated HCT-8 cells to support C. parvum infection was also tested. The 
infected culture was kept in contact with curcumin over the entire incubation period of 24 h by 
replacing medium with fresh medicated medium at 12 h intervals. Resume of parasite multiplication 
was determined following withdrawal of drug exposure for 24 h. To study the effects on infectivity 
oocysts were pre-treated with curcumin for 12 or 24 h at room temperature before being inoculated 
into monolayer. The effect of curcumin on invasiveness of sporozoites was evaluated in the presence 
of curcumin during the excystation and invasion period of 3 h. Curcumin induced effects were 
demonstrated by comparison with non treated monolayers. Monensin (0.144 µM, Sigma) was used 
as a reference anticryptosporidial drug. 
 
2.4 C. parvum oocyst inactivation studies (Manuscript 3) 
 
The suitability and reproducibility of the cc-qPCR assay for inactivation studies were tested by 
evaluating DVG approved cresol based anticoccidial disinfectants (Neopredisan® 135-1, Menno 
Chemie, Norderstedt, Germany; Aldecoc® TGE, EWABO Chemikalien GmbH & Co. KG, 
Wietmarschen, Germany) and by using thermally treated oocysts. Other products not approved as 
anticoccidial disinfectants applied were Aldecoc® XD (EWABO Chemikalien GmbH & Co. KG, 
Wietmarschen, Germany), IGAVET® FF spezial (aldehyde, COS OHLSEN Chemie & Gerätevertrieb 
GmbH, Geltorf-Esprehm, Germany), bleach (sodium hypochlorite) and KokziDes® (Arthur Schopf 
Hygiene GmbH & Co. KG, Neubeuern, Germany), a disinfectant not yet commercialized. The cc-
qPCR was further analysed for its suitability as an alternative to a standardized chicken infection 
model (DAUGSCHIES et al. 2002) that is approved by DVG for routine screening of anticoccidial 
disinfectants. For inactivation assays, 1 x 106 oocysts were subjected to different treatments over 
different periods and subsequently washed with tap water. The size of inoculum (5 x 104) was 
accordingly adjusted. Percent inactivation was calculated by comparing the parasite DNA copies in 
  Overview of the scientific works    
  
 6 
treated cultures to that of untreated controls. In order to compare inactivation determined by the cc-
qPCR model with inactivation determined by the chicken model as previously reported, a log-dose 
response (log inoculum-log parasite DNA copies) calibration curve was generated from parasite 
DNA isolated from cell cultures infected with a dilution series of oocysts. The respective data were 
transformed into a log dose-response calibration curve to back calculate the number of infective 
oocysts (ID) remaining in each inoculum after treatment by using the formula y = mx + b (‘x’ is log 
ID, ‘y’ is log DNA copies, ‘a’ is slope and ‘b’ is intercept). Percent inactivation was calculated as the 
difference of ID values between treated and untreated control samples. A threshold value was 
proposed for certification of a product to be sufficiently effective against coccidia. 
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Abstract 
 
Oocysts of Cryptosporidium parvum are resistant to environmental conditions and many 
disinfectants. A combination of cell culture and quantitative real time PCR (cc-qPCR) is established 
for evaluation of anticoccidial disinfectants against C. parvum. Cryptosporidium parvum oocysts 
were treated with disinfectants, washed and oocysts were incubated with HCT-8 cell monolayers in 
presence of excystation medium for 3 h. Subsequently, unbound parasites were removed by washing 
with growing medium and the infected monolayers were further maintained in fresh growing 
medium for 48 h. Genomic DNA was extracted from each sample and qPCR performed targeting a 
specific sequence of the 70 kDa heat shock protein gene in order to quantify development. Treatment 
of oocysts with cresolic disinfectants demonstrated dose dependent reduction of viability of oocysts.  
More than 98% inactivations were recorded with at least 2% concentration of cresolic disinfectants 
after 2 h of treatment. Bleach (sodium hypochlorite) at 6% solution induced 92.7 % inactivation of 
C. parvum oocysts after 2 h. Thermally treated oocysts (56 and 70°C for 20 min) demonstrated 
complete inactivation, whereas at 38°C no inactivation was observed. Application of Neopredisan® 
135- 1 and Aldecoc® TGE (4% for 2h) as recommended according to the current guidelines 
stipulated by DVG (German Veterinary Society) consistently inactivated more than 99.5% of 
oocysts. The suggested cc-qPCR method appeared to be suited for standardized testing of 
inactivation measures, particularly for evaluation of chemical disinfectants and thus cc-qPCR is 
proposed as an alternative to the established chicken infectivity model for E. tenella for testing 
anticoccidial disinfectants. A minimum inactivation of 99.5% in cc-qPCR model is claimed as a 
suitable threshold for certification of chemical products for disinfection of coccidia oocysts. 
 
Keywords: C. parvum, cell culture infectivity, quantitative PCR, disinfectants efficacy
 
1. Introduction 
 
Cryptosporidium parvum is a coccidian 
parasite that affects a wide range of hosts 
including humans. Infected hosts shed oocysts 
that are transmitted to new hosts. In general, 
coccidian oocysts are resistant to 
environmental conditions and against many 
disinfectants (Fayer et al., 1996; Barbee et al., 
1999). Hygienic measures in terms of cleaning  
 
and disinfection are essential to reduce the 
infection load in the environment. Methods 
such as in vitro inhibition of sporulation, lysis 
test, assessment of excystation and vital 
staining are performed to test for viability of 
coccidia oocysts but they have limitations 
(Black et al., 1996; Bukhari et al., 2000) as 
these tests do not allow reliable estimation of 
infectivity of oocysts. For instance, 
excystation and vital dye stain are not able to 
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predict the efficacy of UV and ozone 
treatment (Bukhari et. al., 1999, 2000) on C. 
parvum. Sporulation inhibition is not 
applicable to Cryptosporidium as oocysts 
sporulate endogenously (Rommel, 2000). 
Oocyst lysis may overestimate inactivation 
because released sporozoites may still be 
infective. Furthermore, inactivation estimated 
from excystation and lysis of oocysts do not 
reflect in vivo infectivity (Bukhari et al., 
2000). Studies on oocyst infectivity in animal 
infection models after disinfection have been 
reported for Isospora (Straberg and 
Daugschies 2007), Toxoplasma (Hitt and 
Filice, 1992; Garcia et al., 2006; Wainwright 
et al., 2007; Dumetre et al., 2008), 
Cryptosporidium (Korich et al., 1990; Joachim 
et al., 2003) and Eimeria (Daugschies et al., 
2002). The chicken infection model for 
Eimeria tenella oocysts was standardized for 
routine screening of anticoccidial disinfectants 
(Daugschies et. al., 2002) and was approved 
by DVG (German Veterinary Society) as a 
standard test required to certify anticoccidial 
efficacy of disinfectants. Currently 
disinfectants which lead to more than 95% 
reduction of oocyst infectivity in the animal 
model are approved by DVG. However, 
infectivity testing in animal models is costly 
and laborious compared to in vitro studies and 
related to ethical concerns.  Studies on 
infectivity of coccidia including Toxoplasma 
gondii have been performed in cell culture 
(Bunetel et al., 1995; Evans et al., 1999). 
Cryptosporidium  parvum demonstrates many 
developmental attributes common to enteric 
coccidia (O’Donoghue 1995). In vitro culture 
of C. parvum was found to suitably reflect the 
ability of oocysts to cause infection in animals 
(Hijjawi et al., 2001; Shin et al., 2001; 
Rochelle et al., 2002). Real time PCR has been 
applied for quantitative assessment of 
development of Cryptosporidium in a cell 
culture system (Shahiduzzaman et al., 2009a; 
Shahiduzzaman et al., 2009b). The present 
study was aimed to establish whether 
combination of cell culture and quantitative 
PCR (cc-qPCR) is suited to replace the 
currently used chicken model for E. tenella to 
screen anticoccidial disinfectants. 
 
2. Materials and methods 
 
2.1. Parasite and inactivating agents 
 
A field strain of C. parvum was maintained 
through passage in neonatal calves. Oocysts 
were isolated and purified by established 
methods (Najdrowski et al., 2007) and stored 
in phosphate buffered saline (PBS, pH 7.4) 
with streptomycin (200 µg/ml) and 
amphotericin B (5 µg/ml) at 4°C. Medium was 
replaced by fresh stock solution every month. 
Oocysts of less than 3 months of age were 
used in all experiments. The DVG approved 
products (p-Chlor-m-cresol) Neopredisan® 
135- 1(Menno Chemie, Norderstedt, 
Germany) and Aldecoc® TGE (EWABO 
Chemikalien GmbH & Co. KG, 
Wietmarschen, Germany) were used as 
disinfectants.  Other products not approved as 
anticoccidial disinfectants like Aldecoc® XD 
(p-Chlor-m-cresol, EWABO Chemikalien 
GmbH & Co. KG, Wietmarschen, Germany), 
IGAVET® FF spezial (aldehyde, COS 
OHLSEN Chemie & Gerätevertrieb GmbH, 
Geltorf-Esprehm, Germany) and KokziDes® 
(Arthur Schopf Hygiene GmbH & Co. KG, 
Neubeuern, Germany), a disinfectant not yet 
commercialized,  and bleach (sodium 
hypochlorite), were also tested. 
 
2.2. Oocysts disinfection 
 
All disinfectants were diluted in fresh tap 
water to 1.1x of final concentration before use. 
1 x 106 oocysts were transferred to a 1.5 ml 
centrifuge tube and washed twice with PBS to 
remove streptomycin and amphotericin present 
in the stock solution. The oocysts were 
resuspended in 100 µl of tap water and 900 µl 
of the 1.1x concentration of disinfectant was 
added so that the oocysts were incubated at the 
final washing concentration of disinfectant. 
Oocysts were treated in separate 1.5 ml tubes 
for each concentration. The control was 
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incubated in tap water. After disinfection at 
room temperature, the treated oocysts were 
washed thrice in PBS. Oocysts were counted 
and density of oocysts was set to 5 x 104/200 
µl for cell culture inoculation. The oocyst 
suspension was controlled under microscope 
for excystation, destruction or morphological 
changes occurring as a consequence of 
disinfection treatment. 
 
2.3. Cell culture infection 
  
A human ileocaecal adenocarcinoma (HCT-8) 
cell line was used for in vitro cultivation of C. 
parvum as described (Shahiduzzaman et al., 
2009a). About 2 x 105 HCT-8 cells were 
seeded into each well of 24 well culture plates 
in growing medium 24 h before inoculation 
with oocysts. The oocysts (5 x 104 per well) 
were excysted on the confluent monolayer for 
3 h at 37°C with 5% CO2 allowing sporozoites 
to invade the HCT-8 cells. Monolayers were 
washed with growing medium to remove the 
unexcysted, empty or inert oocysts and 
unbound sporozoites. The infection was 
maintained for 48 h post inoculation (h p.i.). 
Control cultures were incubated with untreated 
oocysts, aldehyde treated oocysts, heat 
inactivated oocysts or no oocysts. A series of 
fresh oocyst dilutions (10 to 1 x 105) were 
used to estimate the overall sensitivity of the 
cell culture infection assay and also for 
generating a standard curve to calculate the 
infectivity of oocysts. A dilution series of heat 
inactivated oocysts (70°C for 1 h) were used 
to determine the size of the oocyst inoculum at 
which complete elimination of extracellular 
parasite material is reliably achieved. 
 
2.4. Preparation of DNA 
  
At the end of the incubation period, growing 
medium was removed and monolayers were 
washed thrice with 1 ml of sterile PBS (pH 
7.4). Each monolayer was treated with 200 µl 
of accutase (PAA Laboratories GmbH, 
Coelbe, Germany). Subsequently, the cells 
were collected to 1.5 ml tube and centrifuged 
at 4500 x g for 5 min. The supernatant was 
gently removed by aspiration and the pellet 
was resuspended in 200 µl PBS (pH 7.4). 
DNA from each sample was isolated 
according to the instructions for blood and 
body fluid spin of the QIAamp® mini kit 
(Qiagen, Hilden, Germany). The extracted 
DNA was eluted in 100 µl of elution buffer 
supplied with the kit and the elutate was stored 
at -20°C if not used immediately. 
 
2.5. Real time TaqMan assay 
 
The assay was performed with the primers and 
probe as described previously (Shahiduzzaman 
et al., 2009a). In brief, amplification reactions 
of 25 µl volume contained 1x  AB gene master 
mix (ABgene mastermix, AB gene limited, 
Surrey, England); 300 and 900 nM forward 
[CP_hsp70_fwd (2219-2246) 5´-
aactttagctccagttgagaaagtactc-3´] and reverse 
[CP_hsp70_rvs (2336-2362)  
5´-catggctctttaccgttaaagaattcc-3´] primers 
(each 25 µM, Biopolymer, Ulm, Germany), 
respectively; 200 nM TaqMan probe 
(HSP_70_SNA 5´-
aatacgtgtagaaccaccaaccaatacaacatc-3´) (25 
µM, Biopolymer, Ulm, Germany) and 30 nM 
ROX as a reference dye (1 mM, AB gene). An 
aliquot of 3 µl template was used in each 
reaction tube. The reaction was run in a 
Mx3000P system (Stratagene®, La Jolla, 
USA) under the following conditions: 95°C 
for 15 min (enzyme activation), 40 cycles at 
95°C for 15 s (initial denaturation) and 60°C 
for 1 min (annealing and extension of 
primers). Data represent the mean of 3 
replicates with an acceptable standard 
deviation of less than 0.50. 
 
2.6. Quantitative analysis 
 
The sample DNA copies were obtained from a 
standard curve (calibration curve) generated 
automatically by plotting the log of the initial 
template DNA copy numbers against the Ct 
generated (reported from fluorescence signals 
in qPCR reactions) for each dilution. As the 
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size of the oocyst inoculum increased, the 
Cycle threshold (Ct) values linearly decreased 
corresponding to increase of the rate of 
infection as determined from the number of 
parasite DNA copies. Based on the sample 
DNA copies the percent inactivation was 
usually calculated by using the formula 
[Number of DNA copies for control – DNA 
copies for treated oocysts) / DNA copies for 
control] x 100. 
The cell culture dose response calibration 
curve was generated using MS Excel 
(Microsoft Corp., WA, USA) by plotting the 
log initial DNA copies calculated from 
individual Ct values, to the log inocula in each 
experiment with the equation y = mx +b; 
where x is log oocyst dose, y is log number of 
DNA copies (corresponding to number of 
oocysts excretion), m is slope that reflects 
infection rate and b is intercept that reflects 
percent infectivity. Similar to the reference 
chicken model the number of oocysts 
remaining infective (infective dose = ID) was 
calculated as follows:  
 
[(ID value for untreated control oocysts – ID 
value for treated oocysts / ID value for 
untreated control oocyst] x 100 
 
All data were statistically analyzed using 
GraphPad Prism® version 5.0 (GraphPad 
software Inc., La Jolla, CA, USA). Difference 
in the slope and intercept among the 
calibration curves were determined using a 
linear regression model. t test was performed 
to determine the difference in infectivity 
between the chicken infection and cell culture 
infection models. Non-linear regression using 
a sigmoidal model was used to calculate the 
50% infectious dose (ID50). Pearson 
correlation was used to show the relationship 
between two variables. 
 
3. Results 
 
3.1. Cell culture assay sensitivity 
 
Ct values generated against standard dilution 
of oocysts provided a significant (p < 0.05) 
linear correlation (r2) at 24 h p.i. (r2 = 0.996) 
and 48 h p.i. (r2 = 0.992) with lower Ct after 
the longer incubation period (Fig. 1.). For 100 
oocysts, inconsistent fluorogenic signals (1 of 
3 replications) in qPCR were observed at 24 h 
p.i. but signals were constant (3 of 3) with a 
mean Ct value of 35.08±0.11 at 48 h p.i. A 
similar inconsistency was observed for 
samples inoculated with 10 oocysts at 48 h p.i. 
and no signals were recorded for this 
inoculation level at 24 h p.i., indicating a 
lower detection limit of 100 oocysts after 24 h 
p.i. and 10 oocysts after 48 h p.i.  Inoculation 
with up to 1 x 105 heat inactivated oocysts did 
not produce any signal, showing that 
extracellular oocysts are successfully removed 
from monolayers by the applied washing 
procedure (data not shown). 
 
 
Fig. 1. Regression curve calculated for Ct of cell 
cultures infected with serial dilution of 
Cryptosporidium oocysts (p < 0.001). 
 
3.2. Oocysts inactivation 
 
Microscopic investigation of treated 
(disinfectants or temperature) C. parvum 
oocysts did not reveal any excystation or 
destruction of oocysts irrespective of 
disinfectant concentration and time. The cell 
culture incubation with oocysts treated by a 
range of concentrations of Neopredisan® 135- 
1 demonstrated a dose dependent significant (p 
< 0.001) reduction of viability of oocysts (r2 = 
0.929, fig. 2). At 4% concentration infectivity 
was reduced by 99.91, 99.91 and 98.50% after 
2 h of incubation with Neopredisan® 135- 1,  
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Fig. 2. Percent inactivation of oocysts treated with 
different concentrations of Neopredisan® 135- 1 for 2 
h. Error bar represents standard deviation of mean. 
 
Table 1  
Inactivation measurement of C. parvum 
oocysts in cell culture model 
Oocysts treatment   (%inactivation ± 
SD) 
Thermal (20 min)  
70°C 100 ± 0.01 
56°C 100 ± 0.01 
38°C 0 ± 0.25 
Neopredisan® 135- 1 (2 h)   
1%  93.93 ± 2.38 
2%  99.21 ± 0.57 
3%  99.11 ± 0.73 
4% a 99.91 ± 0.08 
Aldecoc® TGE  (2 h)  
1%  89.19 ± 1.29 
2%  98.47 ± 0.57 
4% a 99.91 ± 0.05 
Aldecoc® XD (2 h)  
2%  79.11 ± 3.74 
4%  98.50 ± 0.36 
IGAVET FF spezial (2 h)  
2%  - 0.01 ± 0.01 
4%  - 0.16 ± 0.22 
Bleach (2 h)  
3% 73.57 ± 5.78 
4% 83.09 ± 1.86 
6% 92.7 ± 1.39 
SD is standard deviation of mean of sample replicates 
from at least two experiments. 
aConcentration approved for anticoccidial disinfection 
according to DVG guidelines. 
 
Aldecoc® TGE and Aldecoc® XD, 
respectively. Application of 2% Neopredisan® 
135- 1 for 2 h demonstrated 99.21% reduction 
of infectivity whereas 98.47% reduction was 
observed for Aldecoc® TGE at similar 
conditions. The effect of Aldecoc® XD at 2% 
for 2 h was lower with a mean inactivation of 
79.11%. IGAVET FF spezial, an aldehyde 
containing product, was completely unable to 
inactivate C. parvum oocysts at any 
concentration used. Cryptosporidium parvum 
oocyst exposure to 6, 4 or 3% bleach solution 
for 2 h resulted in 92.7, 83.09 and 73.57% 
mean inactivation, respectively. Applying a 
range of temperature to inactivate C. parvum 
oocysts resulted in a complete inactivation at 
56 and 70°C for 20 min whereas no 
inactivation was found at 38°C (Table 1). 
KokziDes® demonstrated a dose and time 
dependent reduction of oocysts viability by cc-
qPCR. Application of 4, 3, 2 and 1% 
concentration of KokziDes® resulted in a 
mean reduction of 99.87, 99.86, 99.85 and 
86.02 % viability of oocysts, respectively, 
after 2 h of incubation (Table 2).   
 
The individual log dose-response linear 
association provided four calibration curves 
(equations) from four replicate sets (different 
oocyst lots of same size) of  cell culture 
experiments termed as calibration curve- A, B, 
C, and D; [A, (y = 0.8173x + 1.1209),  
correlation- r2 = 0.9948; B, (y = 0.9356x + 
0.5266), r2 = 0.9961; C, (y = 0.9429x + 
0.7175), r2 = 0.9954; D, (y = 0.9492x + 
0.9937), r2 = 0.9953]. Regression analysis of 
log dose- response provided no significant 
differences between slope of calibration curve 
B, C and D (p = 0.883), indicating the 
homogeneity of experimental conditions and 
of oocyst lots regarding cell culture infectivity. 
The slope of calibration curve A differed 
significantly (p < 0.0001 values). The 
differences in mean inactivation values 
between the two calculation systems 
(calculation by comparing DNA copies and 
calculation on the basis of ID values) provided 
a minimum level variability (< 0.5% CV) 
indicating homogeneity of results obtained 
from both calculations (Table 3). 
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Table 2  
Effects of KokziDes® on infectivity of C. parvum oocysts in cell culture model 
 
Concentration 4% 3% 2% 1% 
Hour of 
incubation 
1 h 2 h 1 h 2 h 1 h 2 h 1 h 2 h 
Trial 1 (% 
inactivation) 
99.62 
99.67 
99.61 
99.84 
99.89 
99.90 
99.50 
99.31 
99.38 
99.82 
99.89 
99.88 
99.08 
99.20 
99.02 
99.78 
99.90 
99.87 
69.02 
69.02 
66.33 
87.02 
85.82 
85.21 
Trial 2 (% 
inactivation) 
99.63 
99.57 
99.51 
99.77 
99.83 
99.81 
99.47 
99.51 
99.47 
99.74 
99.79 
99.87 
 
- 
 
- 
56.41 
55.35 
55.73 
90.26 
91.50 
91.32 
Individual data represents sample replicate within the trial 
 
Table 3  
Comparison of percent inactivation data in the cc-qPCR model for chemical disinfectants at 4% 
concentration and 2 h of incubation  
 
b(% inactivation) by comparing ID 
values 
Calibration curves 
Disinfectant 
 
a(%inactvation) by 
comparing DNA 
load 
A B C D 
c(%CV) 
Neopredisan® 
135- 1 
99.8 
100 
99.92 
99.95 
99.98 
99.98 
99.87 
99.94 
99.95 
99.86 
99.94 
99.95 
99.86 
99.94 
99.95 
0.05 
0.03 
0.02 
Aldecoc® 
TGE 
99.98 
99.86 
99.9 
100 
99.96 
99.97 
99.99 
99.9 
99.93 
99.99 
99.9 
99.92 
99.99 
99.89 
99.92 
0.01 
0.03 
0.02 
Aldecoc® XD 98.06 
98.5 
98.95 
99.15 
99.42 
99.6 
98.45 
98.88 
99.19 
98.4 
98.84 
99.16 
98.36 
98.8 
99.14 
0.37 
0.30 
0.22 
Individual data represents the mean value of sample replicates at each trial 
aPercent inactivation = [Number of DNA copies for control – DNA copies for treated oocysts) / DNA  copies for control] 
 x 100 
bPercent inactivation = [(ID value for untreated control oocysts – ID value for treated oocysts) / ID value  for untreated 
control oocysts] x 100 
ccoefficient of variation between a and b  
 
4. Discussion 
 
For the purpose of certification of disinfectants 
reproducibility of test results is crucial (Marx, 
1995). The cc-qPCR applied for assessment of 
drugs against Cryptosporidium 
(Shahiduzzaman et al., 2009a; Shahiduzzaman 
et al., 2009b) along with some modifications 
appears also to be suitable for quantification of  
 
 
oocyst inactivation and thus may replace the 
animal infection model currently used. Cell 
culture infection with ten fold serial dilutions 
of viable oocysts (1 x 105 to 10) displayed a 
significant correlation to qPCR results 
indicating sensitivity and reliability of cc-
qPCR and provides means for reliable 
quantification of oocyst inactivation. 
Consistent and reliable detection of infection 
in monolayers infected with an extremely low 
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dose is increased by longer incubation 
reflecting the longer time that it takes the 
parasite to multiply to a detectable level. This 
is in accordance with the study of Keegan et 
al. (2003). The cell culture standard curve 
generated in our assay is compatible with the 
plasmid standard used in previous studies 
(Fontaine and Guillot, 2002; Shahiduzzaman 
et al., 2009a). 
 
Table 4: Comparison of percent inactivation 
data for the infectivity models 
 
Percent oocysts 
inactivation 
 Disinfectant 
 
Treatment 
(2 h) 
aChicken 
model for 
E. tenella 
Cell 
culture 
model for 
C. parvum 
3% 92.9 99.40 
4% 96.8 99.93 
3% 90.6 99.11 
bNeopredisan
® 135-1 
4% 95.2 99.91 
bAldecoc® 
TGE 
4% 95.5 99.91 
3% 95,5 99.86 cKokziDes
® 4% 99,93 99.87 
adata from animal experiments (according to DVG 
guideline) routinely performed to test anticoccidial 
disinfectants at institute of Parasitology, Universität 
Leipzig , Germany 
bDVG approved disinfectants (recommended 
concentration 4% for 2 h)  
cproduct not yet commercialized 
 
The suitability and reproducibility of the cc-
qPCR assay for inactivation studies were also 
tested by using thermally treated oocysts. The 
results were comparable to those obtained by 
Najdrowski et al. (2007). The current assay 
was further validated by testing anticoccidial 
disinfectants approved by DVG (update list 
published each year; e.g. Böhm, 2000). The 
suitability of Neopredisan® 135- 1 as an 
anticoccidial disinfectant has been well 
documented by a variety of methods. However 
efficacy has been found to vary depending on 
the concentration and time of oocyst exposure 
to the disinfectant. In the present study 
Neopredisan® 135- 1 resulted in a significant 
dose dependent reduction of infectivity and 
was found to be consistently effective over 
99.5% at 4% concentration for 2 h. This is 
similar to the in vitro results observed by 
Eckert (2001) and Najdrowski et al. (2007). 
Lower effectiveness of Neopresdisan® at 2% 
and 3% concentration for 2 h was in 
accordance with the in vivo results reported by 
Joachim et al. (2003). Bleach solution at 6% 
concentration resulted in a reduction of 92.7% 
infectivity. A significant reduction of lesion 
scores in mice was observed by Fayer (1995) 
after incubation of oocysts with 5.25 or 2.63% 
of bleach, however, variation of estimation of 
oocysts is to be expected when different 
methods are applied.  No inactivation was 
found when oocysts were treated with 
Aldehyde (IGAVET FF® Special) in our 
assay. Inactivation determined by both the in 
vitro (Table 2) and the in vivo model (Table 4) 
for KokziDes® ( 3% concentration for 2 h)  
exceeded the threshold value of 95 % (in vivo) 
and 99.5 % (in vitro). Thus KokziDes® was 
found to be active against C. parvum and E. 
tenella and parallel testing of the product in 
both models showed that the threshold value 
of 99.5 % for C. parvum appears suitable. 
 
The main objective of this study was to 
analyse whether cc-qPCR has the potential to 
replace the established chicken infection assay 
with E. tenella for standardized testing and 
certification of disinfectants. The infection 
responses in cell culture for C. parvum were 
compared with the infection response in 
chicken model for E. tenella (Daugschies et al. 
2002). Regression analysis of log dose-
response linear associations from cell culture 
infection with four oocysts lots of same size 
revealed no significant differences between 
slopes (reflecting no significant variation in 
infection rate) but intercept differed to some 
extend reflecting lot to lot variation in 
infectivity, which is supported by the results 
of Slifko et al. (2002). However, these 
differences did not give a remarkable effect on 
calculation of infectivity. The variability in 
infectivity has to be considered by calculating 
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results in comparison to control cultures 
within each experiment. Inter or intra 
experiment variation in both the infection rate 
(slope) and percent infectivity (intercept) are 
often observed in animal model (Daugschies et 
al., 2002; Rochelle et al., 2002; Slifko et al., 
2002). The advantage of the cc-qPCR model 
over these limitations of animal models are 
well defined experimental conditions that can 
be fully standardized and do not underlie 
individual variations of animals.  
 
Linear correlation between inoculation dose 
and infection response is a suitable basis to 
back calculate the actual number of infective 
oocysts after disinfection. Percent inactivation 
calculated as a difference of DNA copies was 
not significantly different from the percent 
inactivation calculated on basis of ID values. 
This study along with previous reports 
confirms that the dose response in cc-qPCR 
appears to be at least as suitable for 
disinfection testing as the animal assay. A 
significant and reproducible dose response 
relationship in cell culture is most important to 
obtain reliable data on disinfectants efficacy.  
Comparison of the log10 normalized ID50 (50% 
of infectious dose) values calculated for both 
models by t- test suggests that C. parvum 
infectivity in cell culture is statistically 
different from E. tenella infectivity in the 
chicken model (p<0.05). However, the 
sensitivity in both models correlated 
significantly (r2 = 0. 9795; p<0.05). Relative 
inactivation calculated for C. parvum in cc-
qPCR was higher than in the chicken model 
for E. tenella (Table 4) at the respective 
inactivation conditions. Variations in effects of 
a disinfectant between these two models are 
attributable to structural and biological 
differences of oocysts of C. parvum and E. 
tenella and the method of 
detection/quantification. In the chicken model 
a minimum of 95% inactivation is claimed as 
the threshold for certification of a product to 
be suitable for anticoccidial disinfection. For 
cc-qPCR the threshold value has to be set to a 
higher relative value to preserve the strict 
conditions for assessment of disinfectants. It is 
shown in this study that all products that 
proved efficient in the chicken model 
exceeded the proposed 99.5% threshold in 
CC-qPCR whereas disinfectants without 
sufficient efficacy on E. tenella remained 
below this level. Based on the current results a 
minimum of 99.5% inactivation is proposed 
for certification of a product to be sufficiently 
effective. Application of the recommended 
concentration (4% for 2 h) approved by DVG 
for Neopredisan® 135- 1 and Aldecoc® TGE 
on basis of the chicken infection assay 
consistently exceeded the postulated threshold 
value of 99.5% postulated for cc-qPCR. Thus 
cc-qPCR is considered to be a suitable 
alternative for the chicken infectivity model 
for testing and approval of anticoccidial 
disinfectants. 
 
In conclusion, cc-qPCR is simple and robust 
for routine screening of disinfectants against 
C. parvum. This model for C. parvum can be 
considered as equivalent to the chicken 
infectivity model for E. tenella regarding 
linear association of the log dose-response 
curve and sensitivity. It is proposed that 
consistent effects of a disinfectant for each of 
at least three replicate samples must be ≥ 
99.5% inactivation to certify a product as a 
suitable anticoccidial disinfectant.  
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4 Summary of results and discussion 
 
The optimized cell culture infection provided reliable and reproducible estimation of parasite 
multiplication in culture. The efforts for conducting the studies led to a better understanding of C. 
parvum cell culture infectivity and analysis. The current studies serve the purpose for the 
quantitative evaluation of new potent drugs and disinfectants under in vitro conditions. The 
proposed method meets the urgent need for a rapid, reliable and workable experimental model for 
evaluation of drugs and disinfectants against cryptosporidia and may replace animal models such 
the chicken infection model that is mandatory for testing and certification of anticoccidial 
disinfectants in Germany. 
 
4.1 Standardized cell culture infectivity assay (Publication 1, 2 and Manuscript 3) 
 
The initial seeding of 2 x 105 HCT-8 cells/well (24 well microplate) and of 1 x 106 HCT-8 
cells/well (6 well microplate) were best suited for subsequent infection with 5 x 104 and 2.5 x 105 
oocysts, respectively. Under optimized cell culture infection conditions a period of 48 h incubation 
delivered maximum parasite numbers without any alteration of host cell monolayers and enabled 
reliable (accurate and reproducible) assessment of parasite multiplication in culture. Thermally 
inactivated oocysts (less than 1 x 105) did not produce any signal in qPCR indicating complete 
removal of inert or unexcysted oocysts by the applied washing procedure.  
 
Monolayers were seeded with serial dilutions of oocyst suspensions (106 to 1) and subsequent 
qPCR resulted in a linear correlation of the log of the initial template DNA copy numbers against 
the Ct generated for each dilution. Infection with at least 10 oocysts was detectable after 48 h p.i. 
and with 100 oocysts after 24 h p.i. The detection limit was 102 copies for plasmid DNA or 25 
oocysts corresponding to 100 sporozoites. Assay quality was similar whether cell culture, plasmid 
DNA or infected control culture DNA was used for calibration and independent of size or type of 
the culture plate (24 or  6 wells) and  range of template DNA (120-700 ng/reaction) indicating the 
flexibility and reliability of the assay. The incubation period of infected cultures may influence 
sensitivity of detection and subsequently the end point results, however, selection of the 
appropriate time depends on e.g. the period expected for the applied drugs to exert the maximum 
effect during the course of development. Longer incubation increases the chance to detect 
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successful infection from a low number of viable oocysts and is needed for assessment of 
inactivation measures e.g. application of disinfectants. 
 
4.2 In vitro drug screening (Publication 1) 
 
The toxicity of the applied drugs was assessed by microscopical alteration of the monolayers and 
individual HCT-8 cells. The results reported here for monensin (98% parasite growth inhibition at 
0.144 µM after 27 h p.i. without toxicity to host cells) supports results of previous studies (MC 
DONALD et al. 1990, ARMSON et al. 1999, NAJDROWSKI et al. 2007). Halofuginone is used 
for treatment of cryptosporidiosis in calves, however, has limited efficacy (LEFAY et al. 2001, 
JOACHIM et al. 2003). In vitro efficacy was very clear (99% inhibition at 1 µM after 27 h p.i.) 
which is in accordance with previous reports (NAJDROWSKI et al. 2007).  Inhibition of parasite 
proliferation was increased after 15 h p.i. and was much more pronounced at 27 and 45 h p.i. Dose 
dependent significant (P ≤ 0.05) reduction of parasite multiplication was recorded for each of the 
applied drugs. A maximum of 98% inhibition was found after application of 24.5µM miltefosine at 
45 h p.i. The relative parasite DNA copy number calculated after the drug exposure compared to 
the initial reference value (3 h p.i., before administration of drug) demonstrated to  97% 
(monensin), 99% (halofuginone) and 96% (miltefosine) reduction in multiplication compared to the 
non treated control at 27 h p.i. Comparing the level of parasite DNA copies over the incubation 
period with the reference value at 3 h p.i. (before application of drugs) the conclusions on efficacy 
and mode of action of the applied drugs (parasitocidal or parasitostatic) are justified. Evaluation of 
miltefosine, an anti-tumor and anti-leishmanial agent (SUNDAR et al. 2000), provided a lower 
level of efficacy than for monensin and halofuginone. Nevertheless, anticryptosporidial potency of 
miltefosine can be deduced from the in vitro data and thus this drug may be further evaluated for 
suitability in the control of cryptosporidiosis. 
 
4.3 In vitro effects of curcumin on C. parvum (Publication 2) 
 
The initial evaluation of toxicity by MTT suggests that curcumin at a concentration of up to 50 µM 
over 24 h was not toxic to HCT-8 cells and accordingly pre-treated cells supported subsequent 
infection and development of C. parvum. Curcumin displayed dose dependent inhibition of 
multiplication of C. parvum and application of fresh curcumin preparation every 12 h greatly 
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increased the effectiveness over the incubation period. The resulting IC50 value of 13 µM indicated 
that C. parvum multiplication inhibition by curcumin was more profound than previously reported 
for Plasmodium (CUI et al., 2007), Giardia (PEREZ-ARRIAGA et al. 2006) and Leishmania 
(KOIDE et al. 2002). Discontinuation of curcumin treatment with 50 and 25 µM after 24 h did not 
allow resumption of C. parvum multiplication in cell culture. Curcumin inhibits (65% at 200 µM 
for 3 h) the invasion of sporozoites to HCT-8 cells. The molecular mechanisms involved are yet to 
be identified. However, curcumin interaction with biomolecular or cellular mechanisms reported 
for other apicomplexan parasites (CUI et al. 2007, SAFFER et al. 1989, SAFFER and 
SCHWARTZMAN 1991) might also affect C. parvum infectivity and development. 
 
4.4 C. parvum oocysts inactivation studies (Manuscript 3) 
 
The applied chemical disinfection or thermal treatment did not induce excystation or destruction of 
exposed oocysts, and thus no loss of oocysts due to treatment was observed before being inoculated 
into cell culture. Application of oocysts treated by a range of concentrations of Neopredisan® 135-
1 resulted in a dose dependent reduction of oocyst viability and the results were similar to those 
obtained by ECKERT (2001), NAJDROWSKI et al. (2007) and JOACHIM et al. (2003). Thermal 
treatment (38, 56 and 70°C for 20 min) of the oocysts showed results that are consistent with those 
obtained by NAJDROWSKI et al. (2007). 
 
The infection responses in cell culture for C. parvum were compared with the previously reported 
infection response in the chicken model for E. tenella (DAUGSCHIES et al. 2002). In four trials 
the calibration curve calculated from parasite DNA copies (as infection response) in cultures 
infected with serial dilutions of a suspension of untreated oocysts (after logarithmic transformation 
of values) showed a clear linear association (r2 = 0.9948 to 0.9961) which provided a suitable basis 
to back calculate the actual number of oocysts remaining infective after disinfection. Use of oocyst 
lots less than 3 months old resulted in similar calibration curves (log dose-log DNA copies) 
indicating homogenous experimental conditions and neglectable variation in cell culture 
infectivity. Lot to lot variability in infectivity did not give a remarkable effect on calculation of 
inactivation because the variability in infectivity is considered by calculating inactivation in 
comparison to control cultures within each experiment. 
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Comparison of the log10 normalized ID50 (50% of infectious dose) values calculated for both  
models by t- test suggests that C. parvum infectivity in cell culture is statistically different from E. 
tenella infectivity in the chicken model (p<0.05). However, the sensitivity in both models 
correlated significantly (r2 = 0. 9795; p<0.05). Results obtained after anticoccidial disinfection 
(Neopredisan® 135-1 and Aldecoc® TGE, DVG listed products published each year; e.g. BÖHM 
2000) at the recommended concentration and time (4% for 2 h) provided effects that consistently 
exceeded 99.5% inactivation. Therefore, 99.5% inactivation is claimed as a suitable threshold value 
for certification of a product to be sufficiently effective against coccidia. Higher inactivation was 
observed in cell culture model for C. parvum than in the chicken model for E. tenella at the 
respective inactivation conditions. Variations in effects of a disinfectant between these two models 
are attributable to structural and biological differences of oocysts of C. parvum and E. tenella. 
Aledcoc® XD, bleach as well as IGAVET® FF spezial did not exceed the threshold. These 
disinfectants are not considered active against cryptosporidia which is in accordance with the 
results of cc-qPCR. Inactivation determined by both the in vitro and the in vivo model for 
KokziDes® (3% concentration for 2 h) exceeded the threshold value of 95 % (in vivo) and 99.5 % 
(in vitro). Thus KokziDes® was found to be active against C. parvum and E. tenella and parallel 
testing of the product in both models showed that the threshold value of 99.5 % for C. parvum 
appears suitable. 
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5 Conclusion 
 
The optimized cell culture infection and quantification assay is suitable for reliable and 
reproducible estimation of C. parvum oocyst infectivity. The cc-qPCR assay was applied 
successfully to evaluate anticryptosporidial drugs and disinfectants. Miltefosine and curcumin 
showed anticryptosporidial activity in this assay, however, the suitability of these drugs for treating 
cryptosporidiosis need to be further tested in animal models. The standardized cc-qPCR may 
replace the chicken infection model for E. tenella as a standard test to certify anticoccidial efficacy 
of disinfectants. 
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Cryptosporidium parvum is an obligatory intracellular parasitic protist that belongs to the phylum 
Apicomplexa. Cryptosporidiosis is an infection for which no satisfactory efficient curative 
treatment is known, especially in immunocompromised individuals. Furthermore, the parasite 
oocysts show considerable tenacity in the environment. Therefore, new potent drugs along with a 
simple and reliable experimental model for evaluation of anticryptosporidial measures are urgently 
needed.  
 
The present studies were undertaken to establish a combined cell culture and quantitative PCR 
assay (cc-qPCR) to assess efficacy of pharmacological compounds against C. parvum. Human 
ileocecal adenocarcinoma cells (HCT-8) were selected for culture of C. parvum. Oocysts were 
excysted directly on confluent monolayers for infection. After 3 h of incubation the non invasive 
parasite remains were removed by washing. At the end of the incubation period the cells were 
harvested and subjected to DNA extraction. Real time PCR was performed to quantify the target 
parasite DNA (fragments of 70 kDa heat shock protein gene) copy numbers. Each reaction was run 
in triplicate. A standard curve calculated on the basis of serial dilutions of plasmid DNA or 
infected control culture DNA was run in each experiment. A series of oocyst suspensions were 
applied to cell cultures to determine the sensitivity of the cc-qPCR assay and also to generate a 
calibration curve to calculate the infectivity of oocysts. A dilution series of heat inactivated oocysts 
(70°C for 1 h) were used to determine the size of the oocyst inoculum at which complete 
elimination of extracellular parasite material by washing is reliably achieved. The results obtained 
by the assays were reproducible and the method sensitive with a detection limit of infection with 10 
oocysts 48 h post infection (p.i.) and with 100 oocysts 24 h p.i. Percent effects of drugs and 
disinfectants were enumerated by comparing DNA copies between treated and non treated samples. 
 
The suitability of cc-qPCR for screening of pharmacological compounds was validated by 
confirming the in vitro efficacy of monensin (98.15% ± 1.09 at 0.144 µM) and halofuginone 
(98.05% ± 0.59 at 25 µM) over the entire incubation period with a dose dependent reduction of 
parasite multiplication demonstrated 27 h p.i. The inhibition of parasite proliferation by 0.144 µM 
monensin in the period from 3 h p.i (time defined to represent the initial level of parasite 
development before drug application) to  27 h p.i. or 45 h p.i. was 97 and 99% respectively, and by 
25 µM halofuginone 99% (27 h p.i.). Hexadecylphosphocholine (miltefosine), a new anti-
leishmanial compound, was tested against cryptosporidia and provided a maximum of 98% 
reduction of parasite multiplication at 45 h p.i.  
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The potential activity of curcumin (extract from the herb Curcuma longa) against C. parvum was 
also evaluated by cc-qPCR. Curcumin appeared to be sensitive to degradation after prolonged 
incubation and the observed inhibition of multiplication of C. parvum was significantly increased 
when medium was replaced by fresh medicated medium after 12 h of exposure. The effects on 
parasite multiplication (>95% inhibition with IC50 value of 13 µM) and on sporozoite invasion 
(assessed 3 h p.i.; 65% inhibition at 200 µM) suggest that further exploration of anticryptosporidial 
efficacy of curcumin may be rewarding.  
 
The cc-qPCR was further optimized to analyse inactivation measures directed against oocysts of C. 
parvum. The suitability of the assay for assessment of inactivation measures was confirmed by the 
reproducible demonstration of effectiveness of cresolic disinfectants at the recommended 
concentration of 4% and incubation period of 2 h (Neopredisan® 135-1, Menno Chemie, 
Norderstedt, Germany: 99.91% ± 0.08; Aldecoc® TGE, EWABO Chemikalien GmbH & Co. KG, 
Wietmarschen, Germany: 99.91± 0.05) and by using thermally inactivated oocysts (complete 
inactivation by 56°C and 70°C for 20 min). Based on the in vitro results and previously obtained 
data from the chicken infection model 99.5% inactivation is proposed as a suitable threshold value 
that needs to be consistently exceeded by a product to be considered efficient.  Application of 
Neopredisan® 135- 1 and Aldecoc® TGE (4% for 2h) consistently inactivated more than 99.5% of 
oocysts while other disinfectants that are not certified as anticoccidial products like Aldecoc® XD 
(EWABO Chemikalien GmbH & Co. KG, Wietmarschen, Germany) and IGAVET® FF spezial 
(COS OHLSEN Chemie & Gerätevertrieb GmbH, Geltorf-Esprehm, Germany) and bleach (sodium 
hypochlorite) did not.  
 
It can be concluded that the cc-qPCR method is suited to easily and reliably assess 
anticryptosporidials in vitro. The method demonstrated that miltefosine and curcumin display 
anticryptosporidial efficacy under the applied conditions. The cc-qPCR is a highly standardized 
method supposedly appropriate to replace the chicken infection model for Eimeria tenella as 
currently practised for certification of anticoccidial disinfectants according to the guidelines of 
DVG (German Veterinary Society).  
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Cryptosporidium parvum ist ein obligat intrazellulärer Protozoe aus dem Stamm der Apicomplexa. 
Für die Kryptosporidiose gibt es derzeit kein hinreichend effizientes Therapeutikum. Die 
infektiösen Oozysten weisen eine hohe Tenazität in der Umwelt auf. Aus diesen Gründen ist die 
Suche nach Wirkstoffen und die Entwicklung eines einfachen und zuverlässigen Prüfmodells für 
gegen Kryptosporidien gerichtete Maßnahmen dringend notwendig. 
 
Die aktuellen Untersuchungen hatten zum Ziel, ein aus Zellkultur und quantitativer PCR 
kombiniertes Verfahren zur Prüfung von Wirkstoffen zu etablieren. Humane ileozäkale 
Adenokarzinomzellen (HCT-8) wurden für die Zellkultur con C. parvum ausgewählt. Die Oozysten 
wurden direkt auf dem konfluenten Monolayer exzystiert und nach 3 h Inkubation die restlichen 
nicht invasiven Stadien durch Waschen aus den Kulturen entfernt. Nach Abschluß der Inkubation 
wurden die Zellen geerntet und DNA extrahiert. Die Zielfragmente der parasitären DNA (70 kDa-
Fragmente des Hitzeschockprotein-Gens) wurden mittels Echtzeit (real time)-PCR quantifiziert. 
Jede Reaktion wurde als Triplikat durchgeführt. Eine Standardkurve wurde auf Basis serieller 
Verdünnungen von Plasmid-DNA oder aus infizierten Kontrollkulturen extrahierter DNA für jeden 
Versuch errechnet. Eine Reihe von Oozystensuspensionen verschiedener Dichte wurde eingesetzt, 
um die Sensitivität des cc-qPCR festzustellen und eine Eichkurve für die Bestimmung der 
Infektiosität der Oozysten zu erhalten. Hitzeinaktivierte Oozysten (70 °C für 1 h) wurden 
verwendet um die höchste Oozystenmenge abzuschätzen, die durch das Waschen der Monolayer 
sicher und vollständig entfernt werden kann. Die Ergebnisse erwiesen sich als reproduzierbar und 
die Methode als sensitiv, indem eine Infektion mit 10 Oozysten 45 h post infectionem (p.i.) und mit 
100 Oozysten 24 h p.i. nachweisbar war. Die in Prozent angegebene Wirkung von Arzneimitteln 
und Desinfektionsmitteln wurde durch Vergleich der DNA-Kopienzahl behandelter und nicht 
behandelter Kulturen bestimmt. 
 
Die Eignung der cc-qPCR für die Prüfung von Pharmaka wurde durch den Nachweis der bekannten 
In-vitro-Wirkung von Monensin (98,15 % ± 1.09 bei 0,144 µM) und für Halofuginon-Bromid 
(98,05 % ± 0,59 bei 25 µM) über den Inkubationszeitraum bestätigt, wobei 27 h p.i. eine 
Dosisabhängigkeit gezeigt werden konnte. Die Inhibition der parasitären Proliferation durch 0,144 
µM Monensin im Zeitraum von 3 h p.i. (definiert als Startpunkt zur Quantifizierung parasitärer 
Entwicklung vor Zugabe der Wirkstoffe) bis 27 h p.i. oder 45 h p.i. lag bei 97 bzw. 99 %. 
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Halofuginon in einer Dosis von 25 µM inhibierte 27 h p.i. zu 99 %. Hexadecylphosphocholin 
(Miltefosin), ein Wirkstoff zur Leishmaniose-Behandlung, wurde gegen Kryptosporidien getestet 
und erreichte 45 h p.i. eine 98 %ige Reduktion der Parasitenvermehrung. 
 
Die potenzielle Aktivität von Curcumin (ein Extrakt aus der Gewürzpflanze Curcuma longa) gegen 
Kryptosporidien wurde ebenfalls mittels cc-qPCR untersucht. Curcumin erwies sich nach längerer 
Inkubation als offenbar instabil und die festgestellte Inhibition war weit deutlicher, wenn 12 h nach 
Zugabe des Präparats das Kulturmedium durch frisch präpariertes medikiertes Medium ersetzt 
wurde. Die Wirkung auf die parasitäre Vermehrung (> 95 % Hemmung, IC50 = 13 µM) und auf die 
Sporozoiten-Invasion (3 h p.i. gemessen; 65 % Hemmung bei 200 µM) lässt weitere 
Untersuchungen zur Wirkung des Curcumins als sinnvoll erscheinen. 
 
Die cc-qPCR-Technik wurde weiter optimiert, um Inaktivierungsmaßnahmen gegen Oozysten von 
C. parvum zu prüfen. Die Eignung des Modells wurde durch den reproduzierbaren Nachweis der 
bekannten Effektivität von Kresol-haltigen Desinfektionsmitteln gemäß der empfohlenen 
Konzentration von 4 % und der Wirkdauer von 2 h (Neopredisan® 135-1, Menno Chemie, 
Norderstedt, Germany: 99,91% ± 0,08 ; Aldecoc® TGE, EWABO  Chemikalien GmbH & Co. KG, 
Wietmarschen, Germany: 99,91± 0,05) und den Einsatz von durch Hitze inaktivierten Oozysten 
(56°C und 70°C über 20 min) belegt. Basierend auf diesen und zuvor im Hühnerinfektionsmodell 
erhobenen Daten werden 99,5 % Inaktivierung als der Schwellenwert vorgeschlagen, den 
chemische Produkte sicher überschreiten müssen, damit sie als ausreichend wirksam gelten 
können. Neopredisan® 135- 1 und Aldecoc® TGE (4%, 2h) zeigten diese Wirkung in allen 
Versuchen, wohingegen andere Desinfektionsmittel wie Aldecoc® XD (EWABO Chemikalien 
GmbH & Co. KG, Wietmarschen, Germany) und IGAVET® FF spezial (COS OHLSEN Chemie 
& Gerätevertrieb GmbH, Geltorf-Esprehm, Germany), die nicht als kokzidienwirksam gelten, 
sowie Natriumhypochlorit diesen Schwellenwert nicht überschritten. 
 
Die cc-qPCR ist eine einfache und zuverlässige Methode, um Wirkstoffe gegen Kryptosporidien in 
vitro zu testen. Es konnte gezeigt werden, dass Miltefosin und Curcumin unter diesen Bedingungen 
eine Wirkung gegen Kryptosporidien haben. Die Methode ist gut standardisierbar und 
möglicherweise geeignet, um die gegenwärtig erforderliche Prüfung von Desinfektionsmitteln auf 
Kokzidienwirksamkeit im Hühnerinfektionsmodell mit Eimeria tenella nach der Richtlinie der 
DVG zu ersetzen.       
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